Recombinant Monoclonal Human anti-Coronavirus SARS-CoV-2 Spike Glycoprotein Antibody (ECD/RBD, WB) LS-C829813

Product Overview

• Article Name: Recombinant Monoclonal Human anti-Coronavirus SARS-CoV-2 Spike Glycoprotein Antibody (ECD/RBD, WB) LS-C829813
• Biozol Catalog Number: LS-C829813-100
• Supplier Catalog Number: LS-C829813-100
• Alternative Catalog Number: LS-C829813-100
• Manufacturer: LifeSpan Biosciences
• Host: Human
• Category: Antikörper
• Application: ELISA, NeA, WB
• Species Reactivity: Virus
• Immunogen: Synthetic peptide corresponding to SARS-CoV-2 Spike Glycoprotein ECD/RBD
• Conjugation: Unconjugated
• Alternative Names: sars-cov-2

Product Description

SARS-CoV-2 Spike Glycoprotein antibody LS-C829813 is an unconjugated human recombinant monoclonal antibody to coronavirus sars-cov-2 Spike Glycoprotein (ECD/RBD). Validated for ELISA, Neut and WB.

Product Properties

• Clonality: Monoclonal
• Concentration: 1 mg/ml
• Buffer: PBS, pH 7.2, 0.02% Sodium Azide, 10% glycerin
• Purity: Affinity-chromatography using epitope-specific immunogen to greater than 95% (by SDS-PAGE).
• Form: PBS, pH 7.2, 0.02% Sodium Azide, 10% glycerin

Application Notes

• Application Dilute: ELISA, Neut, WB (1:500 - 1:1000)
• Application Notes: ELISA Dilution: ECD - 1:320000, RBD - 1:80000